In the Future, We'll All Have STDs. Just like in the Past

The CDC also says that STD rates are on the rise

In the Future, We'll All Have STDs. Just like in the Past

Cases of chlamydia increased by almost seven percent, primary and secondary syphilis cases rose by more than ten percent, and gonorrhea cases soared by almost 19 percent over the past year, according to the CDC data.

Currently, the disease has become resistant to nearly every antibiotic available, with only ceftriaxone proving to be an effective way to treat gonorrhea, and that may soon come to an end.

"We are sliding backward", said Jonathan Mermin, M.D., M.P.H, director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Diagnoses of primary and secondary syphilis rose 76 percent from 17,375 to 30,644. Forty five percent of those cases were among 15-to 24-year-old females.

Of these, 555,608 cases of gonorrhea represented a 67 percent uptick in the same time period. A report has found that cases of syphilis, chlamydia, and gonorrhea have spiked for the fourth year in a row.

"An STD expert says that President Trump should declare this a public health crisis". Primary and secondary syphilis are the most infectious stages of the disease.

"It is evident the systems that identify, treat, and ultimately prevent STDs are strained to near-breaking point".

Most STDs go undiagnosed and untreated, the CDC said, which can cause infertility, stillbirth and an increased risk of HIV.

A lack of sex education also is contributing to the spread of STDs, said Michael Fraser, executive director for the Association of State and Territorial Health Officials.

Finally, the experts said that funding for public health response to STDs has diminished over the years. "If our representatives are serious about protecting American lives, they will provide adequate funding to address this crisis".

The finding adds concerns that azithromycin-resistant genes in some gonorrhea could crossover into strains of gonorrhea with reduced susceptibility to ceftriaxone - and that a strain of gonorrhea may someday surface that does not respond to ceftriaxone.

"They realize that their sites could be stigmatized for being associated with STDs".

Latest News